Global Deep Brain Stimulation Devices Market, By Product Type (Dual-channel Deep Brain Stimulator, Single-channel Deep Brain Stimulator), By Type (Rechargeable, Non-Rechargeable), By Application (Parkinson’s Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder) By End User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Others), By Region, Competition, Forecast & Opportunities, 2017- 2027
The global deep brain stimulation devices market is expected to grow at a robust CAGR of 7.23% to reach a value of USD1826.47 million by 2027. Factors such as the increasing prevalence of neurological disorders and lifestyle diseases such as chronic pain and depression and the growing investments in neurological research & development are driving the global deep brain stimulation devices market. Also, the rise in the awareness among consumers about the benefits of minimally invasive surgery and the growing adoption of technologically advanced products in the healthcare industry is expected to bolster the global deep brain stimulation devices market growth over the next five years.
The old-age population is vulnerable and prone to getting affected by a number of neurological disorders such as Parkinson’s disease, chronic pain, epilepsy, and Alzheimer’s disease. They require treatment from deep brain stimulation devices and play a major role in accelerating the product demand around the globe. Deep brain stimulation devices are minimally invasive targeted surgery and are used to treat movement disorders. The growing popularity of minimally invasive surgery among patients due to its several benefits, including reduced pain, smaller incisions, and quick recovery time span, are expected to significantly influence the market demand in the forecast period.
The global deep brain stimulation devices market is segmented into product type, type, application, end user, region, and company. Based on application, the global deep brain stimulation devices market is segmented into Parkinson’s disease, epilepsy, essential tremor, dystonia, and obsessive compulsive disorder. Parkinson’s disease dominated the market in 2021 with a share of 62.72% of the overall market share. The segment is expected to dominate throughout the forecast period, 2023-2027, due to the growing prevalence of Parkinson’s disease worldwide. Also, the rise in the geriatric population suffering from several neurological conditions and the increasing healthcare expenditure in different economies contribute to the segment growth.
Medtronic Plc, Abbott Laboratories, Inc. (St. Jude Medical), Boston Scientific Corporation, Beijing PINS Medical Co. Ltd, NeuroSigma, Inc., Functional Neuromodulation Ltd., Fisher Wallace, NeuroPace Inc., Renishaw PLC., Aleva Neurotherapeutics SA, LivaNova PLC., SceneRay Corporation, Nevro Corporation, Neuronetics Inc. are the key players operating in the global deep brain stimulation devices market.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027
Objective of the Study:
- To analyze the historical growth and the market size of the global deep brain stimulation devices market from 2017 to 2021.
- To estimate and forecast the market size of the global deep brain stimulation devices market from 2022 to 2027 and growth rate until 2027.
- To classify and forecast the global deep brain stimulation devices market is divided into product type, type, application, end user, region, and company.
- To identify drivers and challenges for the global deep brain stimulation devices market.
- To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global deep brain stimulation devices market.
- To conduct pricing analysis for the global deep brain stimulation devices market.
- To identify and analyze the profile of leading players operating in global deep brain stimulation devices market.
TechSci Research calculated the global deep brain stimulation devices market size using a bottom-up approach, where data for various regions was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Deep brain stimulation device manufacturers, suppliers, distributors, and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to deep brain stimulation devices market
- Market research and consulting firms
Report Scope:
In this report, global deep brain stimulation devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Deep Brain Stimulation Devices Market, By Product Type:
- Dual-channel Deep Brain Stimulator
- Single-channel Deep Brain Stimulator
- Deep Brain Stimulation Devices Market, By Type:
- Rechargeable
- Non- Rechargeable
- Deep Brain Stimulation Devices Market, By Application:
- Parkinson’s Disease
- Epilepsy
- Essential Tremor
- Dystonia
- Obsessive Compulsive Disorder
- Deep Brain Stimulation Devices Market, By End User:
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Neurological Clinics
- Others
- Deep Brain Stimulation Devices Market, By Region:
- North America
Mexico
Canada
- Europe
United Kingdom
France
Italy
Spain
- Asia Pacific
India
Japan
South Korea
Australia
- South America
Argentina
Colombia
- Middle East & Africa
Saudi Arabia
UAE
Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global deep brain stimulation devices marketThe following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Medtronic PLC
2. Abbott Laboratories (St. Jude Medical)
3. Boston Scientific Corporation
4. Beijing PINS Medical Co. Ltd
5. NeuroSigma, Inc.
6. Functional Neuromodulation Ltd
7. Fisher Wallace
8. NeuroPace Inc.
9. Renishaw PLC
10. ALEVA NEUROTHERAPEUTICS SA
11. LivaNova PLC
12. SceneRay Corporation
13. Nevro Corporation
14. Neuronetics Inc.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights
- 1. Product Overview
- 2. Research Methodology
- 3. Executive Summary
- 4. Impact of COVID-19 on Global Deep Brain Stimulation Devices Market
- 5. Voice of Customer
- 5.1. Common Neurological Disorders in Which Deep Brain Stimulation Devices are Used
- 5.2. Preference of Deep Brain Stimulation Devices, By Product Type
- 5.3. Preference of Deep Brain Stimulation Devices, By Type
- 5.4. Brand Awareness
- 6. Global Deep Brain Stimulation Devices Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Product Type (Dual-Channel Deep Brain Stimulator, Single-Channel Deep Brain Stimulator,)
- 6.2.2. By Type (Rechargeable and Non-Rechargeable)
- 6.2.3. By Application (Parkinson's Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
- 6.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
- 6.2.5. By Company (2021)
- 6.2.6. By Region
- 6.3. Market Map
- 7. North America Deep Brain Stimulation Devices Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Product Type (Dual-Channel Deep Brain Stimulator, Single-Channel Deep Brain Stimulator,)
- 7.2.2. By Type (Rechargeable and Non-Rechargeable)
- 7.2.3. By Application (Parkinson's Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
- 7.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
- 7.2.5. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Deep Brain Stimulation Devices Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product Type
- 7.3.1.2.2. By Application
- 7.3.1.2.3. By End User
- 7.3.2. Mexico Deep Brain Stimulation Devices Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product Type
- 7.3.2.2.2. By Application
- 7.3.2.2.3. By End User
- 7.3.3. Canada Deep Brain Stimulation Devices Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product Type
- 7.3.3.2.2. By Application
- 7.3.3.2.3. By End User
- 8. Europe Deep Brain Stimulation Devices Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Product Type (Dual-Channel Deep Brain Stimulator, Single-Channel Deep Brain Stimulator,)
- 8.2.2. By Type (Rechargeable and Non-Rechargeable)
- 8.2.3. By Application (Parkinson's Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
- 8.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
- 8.2.5. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. Germany Deep Brain Stimulation Devices Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product Type
- 8.3.1.2.2. By Application
- 8.3.1.2.3. By End User
- 8.3.2. United Kingdom Deep Brain Stimulation Devices Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product Type
- 8.3.2.2.2. By Application
- 8.3.2.2.3. By End User
- 8.3.3. France Deep Brain Stimulation Devices Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product Type
- 8.3.3.2.2. By Application
- 8.3.3.2.3. By End User
- 8.3.4. Italy Deep Brain Stimulation Devices Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product Type
- 8.3.4.2.2. By Application
- 8.3.4.2.3. By End User
- 8.3.5. Spain Deep Brain Stimulation Devices Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product Type
- 8.3.5.2.2. By Application
- 8.3.5.2.3. By End User
- 9. Asia Pacific Deep Brain Stimulation Devices Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Product Type (Dual-Channel Deep Brain Stimulator, Single-Channel Deep Brain Stimulator,)
- 9.2.2. By Type (Rechargeable and Non-Rechargeable)
- 9.2.3. By Application (Parkinson's Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
- 9.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
- 9.2.5. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Deep Brain Stimulation Devices Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product Type
- 9.3.1.2.2. By Application
- 9.3.1.2.3. By End User
- 9.3.2. India Deep Brain Stimulation Devices Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product Type
- 9.3.2.2.2. By Application
- 9.3.2.2.3. By End User
- 9.3.3. Japan Deep Brain Stimulation Devices Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product Type
- 9.3.3.2.2. By Application
- 9.3.3.2.3. By End User
- 9.3.4. South Korea Deep Brain Stimulation Devices Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Product Type
- 9.3.4.2.2. By Application
- 9.3.4.2.3. By End User
- 9.3.5. Australia Deep Brain Stimulation Devices Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Product Type
- 9.3.5.2.2. By Application
- 9.3.5.2.3. By End User
- 10. South America Deep Brain Stimulation Devices Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Product Type (Dual-Channel Deep Brain Stimulator, Single-Channel Deep Brain Stimulator,)
- 10.2.2. By Type (Rechargeable and Non-Rechargeable)
- 10.2.3. By Application (Parkinson's Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
- 10.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
- 10.2.5. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Deep Brain Stimulation Devices Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product Type
- 10.3.1.2.2. By Application
- 10.3.1.2.3. By End User
- 10.3.2. Argentina Deep Brain Stimulation Devices Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product Type
- 10.3.2.2.2. By Application
- 10.3.2.2.3. By End User
- 10.3.3. Colombia Deep Brain Stimulation Devices Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product Type
- 10.3.3.2.2. By Application
- 10.3.3.2.3. By End User
- 11. Middle East and Africa Deep Brain Stimulation Devices Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Product Type (Dual-Channel Deep Brain Stimulator, Single-Channel Deep Brain Stimulator,)
- 11.2.2. By Type (Rechargeable and Non-Rechargeable)
- 11.2.3. By Application (Parkinson's Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
- 11.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
- 11.2.5. By Country
- 11.3. Middle East and Africa: Country Analysis
- 11.3.1. South Africa Deep Brain Stimulation Devices Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Product Type
- 11.3.1.2.2. By Application
- 11.3.1.2.3. By End User
- 11.3.2. Saudi Arabia Deep Brain Stimulation Devices Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Product Type
- 11.3.2.2.2. By Application
- 11.3.2.2.3. By End User
- 11.3.3. UAE Deep Brain Stimulation Devices Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Product Type
- 11.3.3.2.2. By Application
- 11.3.3.2.3. By End User
- 11.3.4. Kuwait Deep Brain Stimulation Devices Market Outlook
- 11.3.4.1. Market Size & Forecast
- 11.3.4.1.1. By Value
- 11.3.4.2. Market Share & Forecast
- 11.3.4.2.1. By Product Type
- 11.3.4.2.2. By Application
- 11.3.4.2.3. By End User
- 12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
- 13. Market Trends and Developments
- 14. Competitive Landscape
- 14.1. Medtronic PLC
- 14.2. Abbott Laboratories (St. Jude Medical)
- 14.3. Boston Scientific Corporation
- 14.4. Beijing PINS Medical Co. Ltd
- 14.5. NeuroSigma, Inc.
- 14.6. Functional Neuromodulation Ltd
- 14.7. Fisher Wallace
- 14.8. NeuroPace Inc.
- 14.9. Renishaw PLC
- 14.10. ALEVA NEUROTHERAPEUTICS SA
- 14.11. LivaNova PLC
- 14.12. SceneRay Corporation
- 14.13. Nevro Corporation
- 14.14. Neuronetics Inc.
- 15. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook